Aims and scope
Annals of urologic oncology (AUO) (print ISSN: 2617-7765, online ISSN: 2617-7773) publishes the results of novel research in the laboratory and clinical settings, including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human urologic oncology with the overall goal of improving clinical care of patients with urologic tumours. Special topics are arranged in each published issue in the journal, including three main subjects: bladder, prostate and kidney cancer. The journal currently focuses on publishing some reviews and original articles with popular directions and high scientific-reference value to physiopathology, diagnosis and treatment of urologic oncology. Peer-reviewed manuscript types include reviews, original reports, and brief letters.
Currently, every accepted manuscript is free to be published in our journal. There is no charge for the review or publication process for any submitted manuscript.
Some remuneration will be paid to our reviewers and authors to obtain more support from them. A total of 400 dollars (USD) will be paid to the corresponding author or the first author for every accepted manuscript. The author from the editorial board will be paid an extra 200 dollars (USD). A total of 100 dollars (USD) will be paid to the reviewer to give pertinent comments on submitted manuscripts.
Copyright and permission
The Asian Medical Press Limited (Hong Kong, China) reserves copyrights of all published online articles. During the process of manuscript submission, a copyright transfer agreement must be signed by the author who represents all authors listed on the paper. Asian Medical Press Limited (Hong Kong, China) retains permission of each published online article, and any person or institution is forbidden from using the idea, text or data from published articles for a financial purpose. Currently, all published online articles on the Asian Medical Press Limited website are open access to readers worldwide.
Articles published in AUO are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC-BY-NC-ND). The authors and readers can download, reuse, reprint, modify, distribute, and/or copy articles in AUO, so long as the original authors and source are cited. But it is forbid to use our works for commercial purposes or distribute it after remixed, transformed, or built. To know more about creative commons license policies on the website (http://creativecommons.org/licenses/).
Preparing a manuscript for submission to AUO (Click here).
Manuscript template documents
Manuscript template for AUO (Download).
EndNote style for AUO references (Download).
Acceptable article types
Reviews - Authors are encouraged to submit a review on a broad topic of general interest in urologic oncology. It should be well referenced, with at least 5000 words (excluding references) and a minimum of 100 references. Reviews should include 1-6 figures, diagrams or schematics.
Original research - It is acceptable for any original research to identify urologic tumours in the clinic or laboratory with a scientific-reference value. There is no page limit, no reference limit, and no figure number limit.
Letters or comments - Brief letters or comments are welcomed (no more than 500 words and two figures or tables) on recently published articles in the journal.
Brief contents summary for a manuscript
- Title page - The title page should contain the complete title, each author's name, their institutional affiliation and their e-mail address.
- Abstract - The abstract should be "structured" as background, methods, results, and conclusion in original papers but not in review articles or letters.
- Key words - 3 to 5 key words are required.
- Main text - Should include the key components of the work, normally divided into sections and described by short headings. This section contains the introduction, materials and methods, results and discussion for original research articles.
- Ethical policy - Authors must provide approved ethical claims from relative official agents if their research involves animals experiment or/and human participants.
- Authors' contribution - Briefly clarify every author’s role in the submitted manuscript.
- Competing interests - Authors must state whether there are competing interests in a submission among any of the authors.
- Funding - Information about financial support, including the source and number of grants, must be included for each author.
- Acknowledgements - Provided to thank those who have contributed to the research but whose roles were do not warrant authorship.
- References - Please use the journal EndNote style for references using EndNote software (details provided in our template documents).
- Figure legends - Begin with a brief title for the entire figure and continue with a short description of each panel, defining scale bars and abbreviations used (if any). Please do not write the caption below each figure. All figure captions should be listed one after the other here.
- Tables - In tables, footnotes are preferable to long explanatory material in either the heading or body of the table. Such explanatory footnotes, identified by superscript letters, should be placed immediately below the table. Tables should be inserted at the end of the manuscript text.
- Figures - High-resolution figures (300 x 300 dpi) should be saved in the following formats: TIFF/JPEG or EPS, which can be edited. Figures should be submitted as separate files along with the main text word document.
Every submitted manuscript will be checked to identify whether it is original according to the COPE guidelines. Manuscript with plagiarism including any form of copying (text, images, data, idea) without a proper attribution will be not accepted during the peer-review process or retracted after publication.
Conflict of interest
Conflict of interests occur when authors, reviewers or editors have financial (e.g., employment, consultancies, stock ownership, honoraria, paid expert testimony) or personal relationships which will have an effect on their scientific judgment. These financial or personal relationships and academic competition must be declared. The authors can declare conflicts of interest and sources of financial support as acknowledgment. The authors are responsible for presenting a detailed conflicts of interest statement in the end of their main text, even if there are no conflicts to disclose.
Human and animal rights ethical statement
All research involving human participants and animal work must have been approved by the authors' institutional review board or equivalent committee(s) and that board must be named by the authors in the manuscript. For research involving human participants, informed consent must have been obtained (or the reason for lack of consent explained, e.g. the data were analyzed anonymously) and all clinical investigations must have been conducted according to the principles expressed in the Declaration of Helsinki. For a research involving in animals experiments, at the beginning of the Methods section of your manuscript (with the subheading Ethics Statement) enter: "Investigation has been conducted in accordance with the ethical standards and according to the Declaration of Helsinki and according to national and international guidelines and has been approved by the [authors' institutional review board]."
Patients in the research have a right to privacy that should not be infringed without informed consent. Please let us know in the manuscript that whether you have made patients in your research be informed consent.
Manuscript delivery address
Text, figure legends and tables should all be presented in an electronic word document in a logical order according to the manuscript template. Figures should be submitted as separate files along with the word document. All manuscripts should be submitted to the editorial office via the online submission system. Manuscript may be submitted to us by editorial office E-mail (email@example.com) if the online submission is unsuccessful.
Peer review policy
Within the first week following submission, a decision will be made on whether the manuscript will be sent for review or rejected. If accepted for review, a manuscript number will be assigned. More than one expert from our editorial board will review the manuscript carefully. Editors will make a decision on the completely reviewed manuscript, which is normally revision or rejection. Revised manuscripts will be sent for review by the original experts. The final manuscript will be accepted when all experts agree to accept the revised manuscript. If there is disagreement between two experts, the third reviewer will be invited to provide a suggestion to resolve the disagreement. Double blind review is conducted, meaning that both author and reviewer identities are kept from each other. Manuscript with defamation, copyright infringement, competing interest, fabrication or plagiarism will be not accepted.
Proofs will be sent to the authors by e-mail in one month since their articles are accepted. The authors should return the proofs with collections within 7 days.
Our is participating in the crossmark service. View crossmark policy (click here).